Couchbase (BASE)
(Delayed Data from NSDQ)
$17.76 USD
+0.47 (2.72%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $17.74 -0.02 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for Couchbase, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 180 | 155 | 124 | 103 | 83 |
Cost Of Goods | 22 | 20 | 15 | 12 | 8 |
Gross Profit | 158 | 135 | 109 | 92 | 75 |
Selling & Adminstrative & Depr. & Amort Expenses | 242 | 204 | 165 | 125 | 105 |
Income After Depreciation & Amortization | -85 | -69 | -56 | -33 | -30 |
Non-Operating Income | 6 | 2 | 0 | 1 | 7 |
Interest Expense | 0 | 0 | 1 | 7 | 5 |
Pretax Income | -79 | -67 | -57 | -39 | -28 |
Income Taxes | 1 | 1 | 1 | 1 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -80 | -68 | -58 | -40 | -29 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -80 | -68 | -58 | -40 | -29 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -63 | -49 | -40 | -20 | -22 |
Depreciation & Amortization (Cash Flow) | 21 | 20 | 17 | 13 | 9 |
Income After Depreciation & Amortization | -85 | -69 | -56 | -33 | -30 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 47.18 | 44.79 | 25.78 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.54 | -1.49 | -2.37 | NA | NA |
Diluted Net EPS (GAAP) | -1.70 | -1.53 | -2.37 | -7.71 | NA |
Fiscal Year end for Couchbase, Inc falls in the month of January .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | NA | 51.33 | 50.09 | 45.81 | 43.14 |
Cost Of Goods | NA | 5.68 | 5.14 | 5.11 | 5.91 |
Gross Profit | NA | 45.65 | 44.95 | 40.70 | 37.23 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 68.19 | 62.38 | 58.24 | 59.10 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -22.54 | -17.43 | -17.54 | -21.87 |
Non-Operating Income | NA | 1.53 | 1.77 | 1.30 | 1.26 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.02 |
Pretax Income | NA | -21.01 | -20.83 | -16.24 | -20.63 |
Income Taxes | NA | -0.01 | 0.57 | 0.01 | 0.02 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -21.00 | -21.40 | -16.26 | -20.65 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -21.00 | -21.40 | -16.26 | -20.65 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 49.79 | 48.51 | 47.59 | 46.71 |
Diluted EPS Before Non-Recurring Items | NA | -0.40 | -0.32 | -0.34 | -0.44 |
Diluted Net EPS (GAAP) | NA | -0.42 | -0.44 | -0.34 | -0.44 |